Advanced Enzyme Technologies Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sources of funds

Owner's fund

Equity share capital

22.37

22.37

22.36

22.35

22.34

Share application money

-

-

0.64

2.62

3.61

Preference share capital

-

-

-

-

-

Reserves & surplus

558.11

502.97

457.35

410.48

344.54

Loan funds

Secured loans

-

0.01

0.18

0.32

8.62

Unsecured loans

-

-

-

-

-

Total

580.47

525.34

480.53

435.76

379.11

Uses of funds

Fixed assets

Gross block

209.67

200.55

180.53

170.63

158.57

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

67.54

57.69

48.50

39.60

31.62

Net block

142.13

142.86

132.03

131.03

126.95

Capital work-in-progress

21.86

11.03

8.68

7.34

9.96

Investments

256.29

201.47

189.37

184.48

120.85

Net current assets

Current assets, loans & advances

212.66

220.45

199.55

166.40

164.92

Less : current liabilities & provisions

52.46

50.46

49.09

53.49

43.57

Total net current assets

160.19

169.98

150.45

112.91

121.36

Miscellaneous expenses not written

-

-

-

-

-

Total

580.47

525.34

480.53

435.76

379.11

Notes:

Book value of unquoted investments

0.06

0.06

0.06

0.06

1.06

Market value of quoted investments

50.80

15.99

16.68

-

-

Contingent liabilities

17.73

13.69

8.64

11.60

16.05

Number of equity sharesoutstanding (Lacs)

1118.24

1118.24

1118.01

1117.28

1116.78